Tag: y90
Versatility meets control with SIR-Spheres personalised Y90 radioembolization
This advertorial is sponsored by Sirtex Medical.
When performing liver-directed therapy, precise targeting of tumours is crucial to protect healthy liver tissue. Supporting a tailored...
Sirtex Medical granted EU medical device regulation for Y90 resin micospheres
Sirtex Medical has today announced that it has received certification according to European medical device regulation (MDR) 2017/745 for SIR-Spheres Y90 resin microspheres and...
Interventional News’ top 10 most popular stories of May 2024
In May, the most popular stories from Interventional News included a recent investigation into ChatGPT and patient perception of interventional radiology (IR); interventional radiologists...
TARE with Y90 microspheres shows survival benefit and low adverse event...
Etienne Garin (Centre Eugene Marquis, Rennes, France), presenting results from an ad-hoc interim analysis of the PROACTIF trial data, reported that “appropriately selected” patients...
‘A new narrative’: TACE in the age of Y90 and immunotherapy
Hotly debated across the Society of Interventional Oncology (SIO; 25–29 January 2024, Long Beach, USA) annual conference programme, speakers took to the stage to...
ABK Biomedical announce first patient treated in Y90 radioembolization study
ABK Biomedical, a medical device company dedicated to the research, development, and commercialisation of advanced imageable embolic medical devices, has announced the first...
PAIRS 2023: How dogs with seizures inspired novel neuro-oncology trial
On day two of the Pan Arab Interventional Radiology Society annual meeting (PAIRS; 11–14 February, Dubai, UAE), Riad Salem (Northwestern University, Chicago, USA) took...
Authors receive accolade of ‘Abstract of the Year’ at SIR 2022
At the Society of Interventional Radiology (SIR) 2022 Annual Meeting (11-16 June, Boston, USA), four of the abstracts submitted were declared ‘Abstract of the...
Radioembolization paper publication a “landmark moment” for IR-Hepatology collaboration
The cover of June’s edition of the Journal of Hepatology featured a paper on transarterial radioembolization for the treatment of hepatocellular carcinoma (HCC). Publication...
Y90 radioembolization shows promise in treating metastatic pancreatic cancer
Encouraging results from Y90 (yttrium-90) radioembolization of pancreatic cancer support a possible role for it in the management of the disease, with initial small...
